Tailored chemotherapy for colorectal cancer peritoneal metastases based on a drug-screening platform in patient-derived organoids: a case report

医学 奥沙利铂 贝伐单抗 结直肠癌 伊立替康 化疗 丝裂霉素C 温热腹腔化疗 肿瘤科 内科学 癌症 外科 卵巢癌 细胞减少术
作者
Isabel Prieto,Antonio Barbáchano,Nuria Rodrı́guez-Salas,D. Viñal,Delia Cortés Guiral,Alberto Múñoz,Asunción Fernández‐Barral
出处
期刊:Journal of gastrointestinal oncology [AME Publishing Company]
卷期号:14 (1): 442-449 被引量:8
标识
DOI:10.21037/jgo-22-599
摘要

Background: Peritoneal metastasis from colorectal cancer (CRC) has limited therapeutic options and poor prognosis. Systemic chemotherapy combined with cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) or pressurized intraperitoneal aerosol chemotherapy (PIPAC) have yielded initial promising results. However, standard local therapies with oxaliplatin and mitomycin are not optimal and a better individualized management of these patients remains as an unmet clinical need. Patient-derived organoid (PDO) technology allows to culture in three dimensions normal and cancer stem cells (CSC) that self-organize in multicellular structures that recapitulates some of the features of the particular organ or tumor of origin, emerging as a promising tool for drug-testing and precision medicine. This technology could improve the efficacy of systemic and intraperitoneal chemotherapy and avoid unnecessary treatments and side effects to the patient. Case Description: Here we report a case of a 45-year-old man with a rectal adenocarcinoma with liver, lymph node and peritoneal metastases. The patient was treated with systemic chemotherapy (FOLFOXIRI plus Bevacizumab) and was subjected to mitomycin-based PIPAC. We generated patient-derived peritoneal carcinomatosis organoids in order to screen the activity of drugs for a personalized treatment. Both 5-FU and SN-38, the active irinotecan derivative, displayed strong cytotoxicity, while the response to oxaliplatin was much lower. Although the development of a colo-cutaneous fistulae prevented from further PIPAC, the patient continued with fluoropirimidine maintenance treatment based on standard clinical practice and the drug-screening test performed on organoids. Conclusions: Our results suggest that the peritoneal implant shows chemoresistance to oxaliplatin, while it might still be sensitive to irinotecan and 5-FU, which supports a potential benefit of these two drugs in the local and/or systemic treatment of our patient. This study shows the strength of the utility of the establishment of organoids for drug response assays and thus, for the personalized treatment of colorectal carcinomatosis patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
欣慰元蝶完成签到,获得积分10
1秒前
鼠鼠发布了新的文献求助20
1秒前
李刚发布了新的文献求助10
2秒前
是小柠呀发布了新的文献求助10
2秒前
tayyy发布了新的文献求助100
2秒前
2秒前
3秒前
斯文败类的应助被qianzhihe采纳,获得10
3秒前
00发布了新的文献求助10
4秒前
4秒前
steplight完成签到,获得积分10
4秒前
5秒前
ATT完成签到,获得积分10
5秒前
Orange的应助被科研通管家采纳,获得10
6秒前
wendinfgmei完成签到,获得积分10
6秒前
fantasy的应助被科研通管家采纳,获得10
6秒前
烟花的应助被科研通管家采纳,获得10
6秒前
无极微光的应助被科研通管家采纳,获得20
6秒前
molihuakai的应助被科研通管家采纳,获得10
6秒前
爆米花的应助被科研通管家采纳,获得10
7秒前
Owen的应助被科研通管家采纳,获得10
7秒前
Maestro_S的应助被科研通管家采纳,获得10
7秒前
Akim的应助被科研通管家采纳,获得10
7秒前
上官若男的应助被科研通管家采纳,获得10
7秒前
小蘑菇的应助被科研通管家采纳,获得10
7秒前
Nole的应助被科研通管家采纳,获得10
7秒前
7秒前
充电宝的应助被科研通管家采纳,获得10
7秒前
所所的应助被科研通管家采纳,获得10
8秒前
8秒前
8秒前
大模型的应助被科研通管家采纳,获得10
8秒前
JamesPei的应助被科研通管家采纳,获得10
8秒前
Owen的应助被科研通管家采纳,获得10
8秒前
8秒前
科目三的应助被开心德地采纳,获得10
9秒前
星辰大海的应助被科研通管家采纳,获得10
9秒前
完美世界的应助被科研通管家采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187707
求助须知:如何正确求助?哪些是违规求助? 9575782
关于积分的说明 21843037
捐赠科研通 7785576
什么是DOI,文献DOI怎么找? 3435097
关于科研通互助平台的介绍 2559495
邀请新用户注册赠送积分活动 2481986